Search results
Results from the Health.Zone Content Network
of people receiving a COVID-19 vaccine for the first time experienced this side effect. Guillain-Barré syndrome (GBS). GBS is a rare side effect that can cause the immune system to attack healthy ...
The coronavirus disease 2019 (COVID-19) vaccine is important for preventing serious illness and death due to COVID-19. So far, 81.4% of people in the United States have received at least one dose ...
Bell’s palsy. Bell’s palsy is a type of temporary facial paralysis that typically affects one side of the face. The exact cause of Bell’s palsy is unknown, but inflammation or swelling ...
In February 2021, Novavax partnered with Takeda to manufacture the vaccine in Japan, where its COVID‑19 vaccine candidate is known as TAK-019. Novavax signed an agreement with Serum Institute of India for mass scale production for developing and low-income countries.
The Pfizer, Moderna, Novavax, and Johnson & Johnson vaccines are all highly effective in protecting you from the virus that causes COVID-19. The CDC says there’s a preference for the mRNA ...
WebMD's COVID-19 Vaccine reference library for patients interested in finding info on COVID-19 Vaccine and related topics.
e. The Oxford–AstraZeneca COVID‑19 vaccine, sold under the brand names Covishield [31] and Vaxzevria [1] [32] among others, is a viral vector vaccine for the prevention of COVID-19. It was developed in the United Kingdom by Oxford University and British-Swedish company AstraZeneca, [33] [34] [35] using as a vector the modified chimpanzee ...
A cohort study published in the British Medical Journal estimated that only 1.7 out of 100,000 people go on to develop myocarditis or pericarditis within 28 days of getting their COVID-19 vaccine.